PM-LBCL-schema PM-LBCL_R-Benda90.htm http://ascopubs.org/doi/abs/10.1200/JCO.2013.51.7524?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3Dpubmed http://www.bloodjournal.org/content/125/1/33.long?sso-checked=true https://academic.oup.com/annonc/article/22/3/664/258896/Primary-mediastinal-B-cell-lymphoma-treated-with PM-LBCL_AggressieveLymfomen_StadienindelingRemissiebeoordeling_2016.htm http://www.nejm.org/doi/full/10.1056/NEJMoa1214561 PM-LBCL_AggressieveLymfomen_DiagnostiekStadiering_2017.htm PM-LBCL_AggressieveLymfomen_DiagnostiekStadiering_2017.htm PM-LBCL_AggressieveLymfomen_DiagnostiekStadiering_2017.htm http://annonc.oxfordjournals.org/content/21/2/426.full PM-LBCL_AggressieveLymfomen_StadienindelingRemissiebeoordeling_2016.htm PM-LBCL_PECC.htm PM-LBCL_AggressieveLymfomen_DiagnostiekStadiering_2017.htm PM-LBCL_AggressieveLymfomen_DiagnostiekStadiering_2017.htm PM-LBCL_AggressieveLymfomen_DiagnostiekStadiering_2017.htm PM-LBCL_AggressieveLymfomen_DiagnostiekStadiering_2017.htm PM-LBCL_AggressieveLymfomen_DiagnostiekStadiering_2017.htm PM-LBCL_TherapiePrognose_2017.htm PM-LBCL_Lymfoom_FollowUp_curatief.htm PM-LBCL_AggressieveLymfomen_DiagnostiekStadiering_2017.htm PM-LBCL_Overstijgend_Rsc-CVP_2016.htm PM-LBCL_R-CHOP.htm PM-LBCL_Diagnose_2017.htm PM-LBCL_AggressieveLymfomen_StadienindelingRemissiebeoordeling_2016.htm PM-LBCL_TherapiePrognose_2017.htm PM-LBCL_Lymfoom_FollowUp_curatief.htm PM-LBCL_TherapiePrognose_2017.htm